查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468077

2024-2032 年糖尿病视网膜病变市场报告（按类型、治疗类型、最终用户（医院和药房、眼科诊所、门诊手术中心等）和地区）

Diabetic Retinopathy Market Report by Type, Treatment Type, End-User (Hospitals and Pharmacies, Eye Clinics, Ambulatory Surgical Centres, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球糖尿病视网膜病变市场规模达81亿美元。糖尿病盛行率激增、对有效治疗的需求不断增长以及人们对糖尿病视网膜病变早期诊断和治疗的认识不断提高，是推动市场发展的一些关键因素。

糖尿病视网膜病变 (DR) 是糖尿病的常见併发症，会影响视网膜，视网膜是眼睛中感知光线并向大脑发送讯号的部分。当高血糖损害视网膜中的小血管，导致其渗漏或阻塞时，就会发生这种情况。如果不及时治疗，可能会导致视力丧失或失明。糖尿病视网膜病变主要有两种类型，即非增殖性糖尿病视网膜病变和增殖性糖尿病视网膜病变。其诊断涉及全面的眼科检查，其中可能包括萤光血管摄影和光学相干断层扫描等测试。这些测试可以帮助确定 DR 的存在和严重程度，以便进行早期介入和治疗。目前，DR 有多种治疗方案，包括眼内类固醇注射、雷射治疗和玻璃体切除术。眼内类固醇注射有助于减轻眼睛的发炎和肿胀，而雷射治疗可用于密封渗漏的血管并防止视网膜进一步受损。在更严重的情况下，可能需要进行玻璃体切除术以去除眼睛中的血液或疤痕组织。

糖尿病视网膜病变市场趋势：

全球糖尿病视网膜病变市场正在显着成长，这主要是由于糖尿病盛行率上升和老年人口增加所致。同时，主要参与者正在积极致力于开发糖尿病视网膜病变的新治疗解决方案，这正在促进市场成长。除此之外，抗VEGF药物和缓释植入物等新药物和疗法的开发也对市场成长做出了重大贡献。此外，远距医疗和人工智慧（AI）在糖尿病视网膜病变诊断和治疗中的不断采用正在推动市场成长。由于人们对糖尿病视网膜病变及其潜在后果的认识不断增强，对有效治疗的需求不断增长，这是另一个生长诱导因素。此外，人们对糖尿病视网膜病变早期诊断和治疗的认识不断提高，加上眼科技术的进步，正在推动市场的成长。其他因素，例如医疗保健支出的增加、政府改善眼保健服务的各种倡议的实施以及有利的报销政策的出台，正在推动市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球糖尿病视网膜病变市场表现如何，未来几年将如何表现？
  • 全球糖尿病视网膜病变市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球糖尿病视网膜病变市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的糖尿病视网膜病变市场？
  • 依类型划分市场是怎么样的？
  • 糖尿病视网膜病变市场哪种类型最具吸引力？
  • 根据治疗类型的市场划分是怎样的？
  • 糖尿病视网膜病变市场中哪种治疗类型最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 糖尿病视网膜病变市场中哪个是最具吸引力的最终使用者？
  • 全球糖尿病视网膜病变市场的竞争结构如何？
  • 全球糖尿病视网膜病变市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球糖尿病视网膜病变市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 增殖性糖尿病视网膜病变
    • 市场走向
    • 市场预测
  • 非增殖性视网膜病变
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗类型

  • 抗VEGF药物
    • 市场走向
    • 市场预测
  • 类固醇植入物
    • 市场走向
    • 市场预测
  • 雷射手术
    • 市场走向
    • 市场预测
  • 玻璃体切除术
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院和药房
    • 市场走向
    • 市场预测
  • 眼科诊所
    • 市场走向
    • 市场预测
  • 门诊手术中心 (ASC)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alimera Sciences
    • Allergan Plc
    • Ampio Pharmaceuticals
    • Bayer Healthcare
    • BCN Peptides
    • Genentech
    • Kowa Group
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Sirnaomics Inc.
Product Code: SR112024A1932

The global diabetic retinopathy market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The surging prevalence of diabetes, rising demand for effective treatments, and growing awareness regarding early diagnosis and treatment of diabetic retinopathy represent some of the key factors driving the market.

Diabetic retinopathy (DR) is a common complication of diabetes that affects the retina, the part of the eye that senses light and sends signals to the brain. It occurs when high blood sugar levels damage the small blood vessels in the retina, causing them to leak or become blocked. This can lead to vision loss or blindness if left untreated. There are two main types of diabetic retinopathy, namely non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Its diagnosis involves a comprehensive eye exam, which may include tests such as fluorescein angiography and optical coherence tomography. These tests can help to identify the presence and severity of DR, allowing for early intervention and treatment. Currently, there are several treatment options available for DR, including the use of intraocular steroid injections, laser treatment, and vitrectomy. Intraocular steroid injections can help to reduce inflammation and swelling in the eye, while laser treatment can be used to seal leaking blood vessels and prevent further damage to the retina. In more severe cases, a vitrectomy may be necessary to remove blood or scar tissue from the eye.

Diabetic Retinopathy Market Trends:

The global diabetic retinopathy market is witnessing significant growth, primarily driven by the rising prevalence of diabetes and the increasing geriatric population. In line with this, key players are actively working to develop new therapeutic solutions for diabetic retinopathy, which is bolstering market growth. Apart from this, the development of new drugs and therapies, such as anti-VEGF agents and sustained-release implants, has also significantly contributed to market growth. Additionally, the escalating adoption of telemedicine and artificial intelligence (AI) in the diagnosis and treatment of diabetic retinopathy is driving the market growth. The rising demand for effective treatments due to the growing awareness of diabetic retinopathy and its potential consequences is acting as another growth-inducing factor. Furthermore, the surging awareness regarding early diagnosis and treatment of diabetic retinopathy, coupled with advancements in ophthalmic technology, are fueling the market growth. Other factors, such as increasing healthcare expenditure, the implementation of various government initiatives to improve eye care services, and the availability of favorable reimbursement policies, are propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, treatment type and end-user.

Type Insights:

Proliferative Diabetic Retinopathy

Non-proliferative Retinopathy

The report has provided a detailed breakup and analysis of the diabetic retinopathy market based on the type. This includes proliferative diabetic retinopathy and non-proliferative retinopathy. According to the report, the non-proliferative retinopathy segment dominates the market.

Treatment Type Insights:

Anti VEGF Drugs

Steroid Implants

Laser Surgeries

Vitrectomy

The report has provided a detailed breakup and analysis of the diabetic retinopathy market based on the treatment type. This includes anti VEGF drugs, steroid implants, laser surgeries, and vitrectomy. As per the report, the anti VEGF drugs segment holds the largest market share.

End-User Insights:

Hospitals and Pharmacies

Eye Clinics

Ambulatory Surgical Centres (ASCs)

Others

The report has provided a detailed breakup and analysis of the diabetic retinopathy market based on the end-user. This includes hospitals and pharmacies, eye clinics, ambulatory surgical centres (ASCS), and others. As per the report, the hospitals and pharmacies segment leads the market.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America diabetic retinopathy market include the increasing prevalence of diabetes, growing awareness about diabetic retinopathy, and advancements in diagnostic and treatment technologies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global diabetic retinopathy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global diabetic retinopathy market?
  • What is the impact of each driver, restraint, and opportunity on the global diabetic retinopathy market?
  • What are the key regional markets?
  • Which countries represent the most attractive diabetic retinopathy market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the diabetic retinopathy market?
  • What is the breakup of the market based on the treatment type?
  • Which is the most attractive treatment type in the diabetic retinopathy market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the diabetic retinopathy market?
  • What is the competitive structure of the global diabetic retinopathy market?
  • Who are the key players/companies in the global diabetic retinopathy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proliferative Diabetic Retinopathy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proliferative Retinopathy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Anti VEGF Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Steroid Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitrectomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eye Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centres (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Alimera Sciences
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Allergan Plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Ampio Pharmaceuticals
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bayer Healthcare
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 BCN Peptides
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Genentech
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Kowa Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Regeneron Pharmaceuticals Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sirnaomics Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
  • Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
  • Figure 78: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
  • Table 7: Global: Diabetic Retinopathy Market: Key Players